Control of a Prostate Cancer Model Using Intermittent Androgen Suppression*

2018 13th APCA International Conference on Control and Soft Computing (CONTROLO) ◽

10.1109/controlo.2018.8514295 ◽

2018 ◽

Author(s):

Bertinho A. Costa ◽

Joao M. Lemos

Keyword(s):

Prostate Cancer ◽

Cancer Model ◽

Intermittent Androgen Suppression ◽

Androgen Suppression ◽

Prostate Cancer Model

Download Full-text

Can fractional differentiation improve stability results and data fitting ability of a prostate cancer model under intermittent androgen suppression therapy?

Chaos Solitons & Fractals ◽

10.1016/j.chaos.2019.109529 ◽

2020 ◽

Vol 131 ◽

pp. 109529 ◽

Cited By ~ 1

Author(s):

Ozlem Ozturk Mizrak ◽

Cihan Mizrak ◽

Ardak Kashkynbayev ◽

Yang Kuang

Keyword(s):

Prostate Cancer ◽

Data Fitting ◽

Fractional Differentiation ◽

Cancer Model ◽

Intermittent Androgen Suppression ◽

Androgen Suppression ◽

Stability Results ◽

Fitting Ability ◽

Improve Stability ◽

Prostate Cancer Model

Download Full-text

The Impact of Fractional Differentiation in Terms of Fitting for a Prostate Cancer Model Under Intermittent Androgen Suppression Therapy

Mathematical Modelling in Health, Social and Applied Sciences - Forum for Interdisciplinary Mathematics ◽

10.1007/978-981-15-2286-4_5 ◽

2020 ◽

pp. 151-197 ◽

Cited By ~ 1

Author(s):

Ozlem Ozturk Mizrak ◽

Cihan Mizrak ◽

Ardak Kashkynbayev ◽

Yang Kuang

Keyword(s):

Prostate Cancer ◽

Fractional Differentiation ◽

Cancer Model ◽

Intermittent Androgen Suppression ◽

Androgen Suppression ◽

The Impact ◽

Prostate Cancer Model

Download Full-text

1113: Route of Administration Influences the Antitumor Effect of Bone Marrow Derived Dendritic Cells Engineered to Produce Interleukin-12 in A Metastatic Mouse Prostate Cancer Model

The Journal of Urology ◽

10.1016/s0022-5347(18)38350-2 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 293-294

Author(s):

Takashi Saika ◽

Takefumi Satoh ◽

Nobuyuki Kusaka ◽

Shin Ebara ◽

Vladimir B. Mouraviev ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Marrow ◽

Dendritic Cells ◽

Antitumor Effect ◽

Route Of Administration ◽

Interleukin 12 ◽

Cancer Model ◽

Mouse Prostate ◽

Prostate Cancer Model

Download Full-text

Faculty Opinions recommendation of MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13450964.14826065 ◽

2012 ◽

Author(s):

Uri Lindner ◽

Alyssa Louis

Keyword(s):

Prostate Cancer ◽

Molecular Imaging ◽

Contrast Agent ◽

Cancer Model ◽

Targeted Contrast Agent ◽

Prostate Cancer Model

Download Full-text

Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study

BJU International ◽

10.1111/j.1464-410x.2005.05676.x ◽

2005 ◽

Vol 96 (4) ◽

pp. 514-520 ◽

Cited By ~ 45

Author(s):

Shawn Malone ◽

Gad Perry ◽

Roanne Segal ◽

Simone Dahrouge ◽

Juanita Crook

Keyword(s):

Prostate Cancer ◽

Side Effects ◽

Phase Ii ◽

Phase Ii Study ◽

Intermittent Androgen Suppression ◽

Androgen Suppression

Download Full-text

Evaluation of Thermal Therapy in a Prostate Cancer Model Using a Wet Electrode Radiofrequency Probe

Journal of Endourology ◽

10.1089/089277901750426436 ◽

2001 ◽

Vol 15 (6) ◽

pp. 629-640 ◽

Cited By ~ 29

Author(s):

S. Bhowmick ◽

D.J. Swanlund ◽

J.E. Coad ◽

L. Lulloff ◽

M.F. Hoey ◽

...

Keyword(s):

Prostate Cancer ◽

Thermal Therapy ◽

Cancer Model ◽

Prostate Cancer Model

Download Full-text

Intermittent androgen suppression for prostate cancer

Nature Reviews Urology ◽

10.1038/nrurol.2010.141 ◽

2010 ◽

Vol 7 (10) ◽

pp. 552-560 ◽

Cited By ~ 29

Author(s):

Nicholas C. Buchan ◽

S. Larry Goldenberg

Keyword(s):

Prostate Cancer ◽

Intermittent Androgen Suppression ◽

Androgen Suppression

Download Full-text

40. PET/CT Imaging of PSMA-Targeted Human T-Cells in Systemic Prostate Cancer Model

Molecular Therapy ◽

10.1016/s1525-0016(16)39443-6 ◽

2008 ◽

Vol 16 ◽

pp. S16

Keyword(s):

Prostate Cancer ◽

T Cells ◽

Ct Imaging ◽

Cancer Model ◽

Human T Cells ◽

Pet Ct ◽

Prostate Cancer Model

Download Full-text

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

The Prostate ◽

10.1002/pros.20482 ◽

2006 ◽

Vol 66 (14) ◽

pp. 1498-1511 ◽

Cited By ~ 36

Author(s):

Rajasubramaniam Shanmugam ◽

Vetrichelvan Jayaprakasan ◽

Yesim Gokmen-Polar ◽

Stephanie Kelich ◽

Kathy D. Miller ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Hormone Refractory Prostate Cancer ◽

Cancer Model ◽

Hormone Refractory ◽

Prostate Cancer Model

Download Full-text

Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression

Urology ◽

10.1016/j.urology.2004.07.019 ◽

2004 ◽

Vol 64 (6) ◽

pp. 1182-1186 ◽

Cited By ~ 59

Author(s):

Celestia Higano ◽

Andrew Shields ◽

Nathanael Wood ◽

Judy Brown ◽

Cathy Tangen

Keyword(s):

Prostate Cancer ◽

Bone Mineral Density ◽

Bone Metastases ◽

Bone Mineral ◽

Mineral Density ◽

Intermittent Androgen Suppression ◽

Androgen Suppression

Download Full-text